Search results
Some drugmakers to cap cost of asthma inhalers at $35 a month
NBC News via Yahoo News· 3 weeks agoStarting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price...
Widely Used Inhalers Won't Cost More Than $35 a Month, AstraZeneca Says
Gizmodo via Yahoo News· 3 months agoAstraZeneca, the UK-based maker of popular inhalers like Symbicort and Airsupra, announced Monday it...
These Inhalers No Longer Cost More Than $35 Per Month
Verywell Health via Yahoo News· 3 months agoGrace Cary / Getty Images Fact checked by Nick Blackmer Key Takeaways Three major pharmaceutical...
AstraZeneca follows rival, will cap inhaler prices at $35 per month amid scrutiny
WJZY via Yahoo News· 3 months ago(The Hill) — Drugmaker AstraZeneca will cap out-of-pocket costs at $35 for all its inhaler products,...
AstraZeneca capping COPD, asthma medications at $35 a month
Scripps News via AOL· 3 months agoPerson holding an asthma inhaler. Drugmaker AstraZeneca said it intends to cap out-of-pocket prices...
What hedgehogs can teach us about asthma management
Kitsap Sun via Yahoo News· 2 years agoI like stories and metaphors, and I use them both in life and in medicine. I was recently reminded of one of my favorites, the parable of the fox and the...
US FTC disputes over 100 medical patents listed with FDA including asthma inhalers
Reuters via Yahoo News· 8 months agoWASHINGTON (Reuters) -The U.S. Federal Trade Commission (FTC) on Tuesday said it sent letters to...
AstraZeneca (AZN) Follows Boehringer, to Cap Inhaler Cost in US
Zacks via Yahoo Finance· 3 months agoAstraZeneca (AZN) plans to lower the prices of its inhaled respiratory products to $35 per month in...
FTC challenges patents held by nine big drugmakers, citing unfair competition
BioPharma Dive via Yahoo Finance· 7 months agoDive Brief: The Federal Trade Commission is challenging patents for 17 drugs marketed by Abbvie,...
Pharma Stock Roundup: Q3 Earnings of BAYRY, AZN, EU Nod for AZN, SNY RSV Vaccine
Zacks via Yahoo Finance· 2 years agoThis week, AstraZeneca AZN and Sanofi’s SNY RSV vaccine, nirsevimab and Sanofi and GSK’s GSK...